Background
nonadherence, cardiometabolic diseases, DDIs, chronic disease
DISEASE PROGRESSION, CHRONIC DISEASE, DRUG-DRUG INTERACTION
Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring for patients with cardiometabolic diseases. NAs and DDIs are both ubiquitous and often overlooked. We studied a novel chronic disease management (CDM) test to detect medication adherence and the presence and severity of DDIs.